Advent Life Sciences LLP 13D/13G Filings for Iterum Therapeutics plc (ITRM)

Advent Life Sciences LLP 13D and 13G filings for Iterum Therapeutics plc:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2021-02-10
3:40 pm
Purchase
2020-07-0113DIterum Therapeutics plc
ITRM
Advent Life Sciences LLP192,672
3.500%
134,046increase
(+228.64%)
Filing